UCB Wins FDA Approval for Daily ZILBRYSQ Autoinjector for gMG

The syringe remains an option, while the company projects a U.S. launch during the first three months of 2027.
Econotimes has shared only the headline of this report so far. The full story, with all its details, is on Econotimes’s own website.
Read the full report on Econotimes
Story file
- Section
- Business
- First reported by
- Econotimes
- Reporter
- naomi calder
- Published
- Friday, 16 October 2026, 11:29 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Econotimes with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.


